Establishment Labs partners with Meghan Trainor, who shares her experience with Motiva Implants, a new-generation breast implant now available in the U.S.
Establishment Labs Holdings Inc, a global medical technology company focused on breast aesthetics and reconstruction, announced a partnership with GRAMMY Award-winning singer Meghan Trainor. Trainor recently received Motiva Implants.
Trainor Shares Her Experience with Motiva Implants
“Self-confidence and body positivity are so important to me. After losing a bunch of weight and having two kids, I have always struggled loving my breasts because they were never even. I’ve been dreaming about getting this done for so many years. Once I learned about the recent FDA approval of Motiva Implants, I knew this was the perfect time for me,” Trainor said. “I did my research, consulted with several plastic surgeons, and chose Motiva Implants because they offered the look, the smooth silk feel, and the safety I was looking for. There is just such a difference with these new generation implants. I’m absolutely in love with the results—they feel so soft and natural and I’m more confident than ever. I can’t wait to get back on stage with so many new outfit choices.”
Motiva Implants: Design and Features
Motiva Implants, available to patients in the United States since October 2024, feature the patented SmoothSilk surface, which is reportedly designed for enhanced biocompatibility and scientifically shown to promote low inflammation. According to the company, this surface not only helps the tissue around the implant to stay soft, but also has led to an industry-low 0.5% capsular contracture rate.
Motiva SmoothSilk Ergonomix implants feature a unique shape that adapts as the body changes position, maintaining a round shape when lying down and a teardrop shape when standing up. Motiva SmoothSilk Round implants provide increased upper breast fullness and softness while keeping a round full form regardless of position.
Clinical Studies and Patient Satisfaction
Motiva devices, through FDA clinical studies, have reported less than 1% device-related complications and above 97% patient and surgeon satisfaction rates, according to the company.
Establishment Labs on the Partnership
“We could not be more thrilled to partner with Meghan Trainor, an artist who echoes the sentiments we hear from millions of women around the world who choose Motiva for their breast augmentation,” commented Juan José Chacón-Quirós, founder of Establishment Labs. “It is an exciting time for the organization as we are finally able to bring Motiva to women in the United States. These implants were designed to ensure women’s health and well-being. Motiva enables plastic surgeons to perform the surgeries they want and women to get the results they deserve. This is real innovation leading to better patient outcomes. Top plastic surgeons around the US are adopting Motiva Implants rapidly, and many women, like Meghan, are choosing and embracing both the technology and the natural results.”
Motiva’s Global Presence and Scientific Backing
Since first becoming commercially available in 2010, over 4 million Motiva devices have been delivered to plastic and reconstructive surgeons in over 90 countries globally, according to Establishment Labs. The company’s technologies and products are covered by over 200 patent applications in 20 separate patent families worldwide and are supported by over 100 clinical and scientific studies and peer-reviewed publications.
Plastic Surgeon on the Benefits of Motiva Implants
“When Meghan came to me, I was excited to offer her Motiva Implants. These implants are so much better than anything that has been available on the US market. They are designed not only to achieve my patients’ aesthetic goals but also to ensure the highest quality and safety, backed by years of research and scientific data that show some of the lowest complication rates,” said Payman Danielpour, MD, a board-certified plastic surgeon in Beverly Hills, Calif. “Since their approval, I’ve been using Motiva Implants almost exclusively and couldn’t be more pleased with the results. Motiva is a new generation of implants and I’m thrilled that Meghan, and women across the US, now have access to such an advanced device. I’ve already seen their incredible impact on many patients in my practice.”
Photo: Establishment Labs
